FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,663,257 | -27.5% | 3,555,871 | +62.3% | 0.19% | -30.7% |
| Q1 2024 | $16,077,595 | -25.1% | 2,190,408 | +505.1% | 0.28% | -33.2% |
| Q3 2021 | $21,456,000 | -18.7% | 362,000 | +19.1% | 0.42% | -10.7% |
| Q2 2021 | $26,384,000 | +5.3% | 304,000 | 0.0% | 0.47% | -11.0% |
| Q1 2021 | $25,065,000 | -51.1% | 304,000 | -46.1% | 0.53% | -48.0% |
| Q4 2020 | $51,291,000 | +92.1% | 564,067 | -15.6% | 1.01% | +56.0% |
| Q3 2020 | $26,703,000 | -14.8% | 668,067 | -26.9% | 0.65% | -28.8% |
| Q2 2020 | $31,352,000 | -12.7% | 913,775 | -43.5% | 0.91% | -19.9% |
| Q1 2020 | $35,913,000 | -8.4% | 1,616,993 | -19.3% | 1.14% | -8.8% |
| Q4 2019 | $39,191,000 | +29.2% | 2,002,605 | +2.5% | 1.25% | +1.1% |
| Q3 2019 | $30,328,000 | -12.3% | 1,952,897 | +14.7% | 1.24% | -0.5% |
| Q2 2019 | $34,569,000 | +15.5% | 1,702,897 | 0.0% | 1.24% | +8.3% |
| Q1 2019 | $29,920,000 | +40.9% | 1,702,897 | +2.9% | 1.15% | +34.9% |
| Q4 2018 | $21,232,000 | +11.1% | 1,654,865 | +41.0% | 0.85% | +24.1% |
| Q3 2018 | $19,118,000 | – | 1,173,617 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
| Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
| Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
| Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
| Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
| Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
| Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
| Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
| Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |